J2 Ventures

J2 Ventures is an early-stage venture firm founded in 2019 that backs dual-use technology at the seam between frontier science and national security, investing from pre-seed through Series B and beyond. Disclosed assets under management stand at $175 million, while its SEC filings trace a considerably wider platform: a $26.3 million second fund closed in 2021, a $120 million Argonne Fund noticed in 2023 with a parallel vehicle at the same size, and a $250 million Brookhaven Fund noticed in November 2025, all organized as Massachusetts limited partnerships.

The investment surface is advanced computing, biomedical engineering, cybersecurity and infrastructure, with adjacent exposure to aerospace and defense, digital health, consumer and fintech. Portfolio management teams include Paravision in computer vision, Holly in AI-driven hiring for government, Micron Biomedical in needle-free injection, Tasso in at-home blood collection, Nametag in passwordless identity, Cinder in trust and safety, Plato Systems in industrial sensing and SkyFi in satellite imagery distribution.

What distinguishes J2 is the composition of the firm itself. Co-founders and managing partners Alexander Harstrick and Jonathan Bronson have assembled PhD scientists, combat veterans, practicing physicians and operators, plus a director of federal solutions on staff, and they run a lettered series of Strategic Opportunities partnerships that concentrates extra capital into individual winners outside the main funds. That structure is built for companies whose first serious customer is a government agency, where procurement literacy matters as much as product velocity.